Tesla CEO Elon Musk is set to head to trial later this year over a series of bad tweets in which he described a diver as “pedo guy” after the man criticized his plan for saving a young soccer team trapped in a cave system in Thailand.
The news comes after Vernon Unsworth—who helped in the rescue effort to free the boys from the Tham Luang Nang Non cave system last summer—filed a defamation suit in September over Musk’s repeated claims that the diver was a pedophile. In December, lawyers for Musk filed a motion to have the lawsuit dismissed, arguing that “over-the-top insults are not statements of fact.”
That motion was denied by U.S. District Judge Stephen V. Wilson, the Verge reported Friday, in part because of the way that Musk communicated the assertion, both on Twitter as well as in emails to BuzzFeed News.
Wilson determined that given “the totality of the circumstances—including the general context of Defendant’s statements, the specific context of the statements, and the statements’ susceptibility of being proved true or false—a reasonable factfinder could easily conclude that Defendant’s statements, as pleaded in the Complaint, implied assertions of objective fact.”
A spokesperson for Tesla did not immediately return a request for comment.
Anti-Aging Enzymes. Research has concluded that two enzymes SIRT3 and SIRT4 are responsible for the process of aging. The cells’ ability to divide and reproduce when hindered shows the signs of aging on humans. If science can restore the depleted cells, the effects of aging can be eliminated. For easy understanding, let us compare the process of aging with the analogy of a battery. A used battery can be recharged, similarly the cells can be repaired and restored in order to remove the effects of aging or even more stop the process. Above explanation implies that in the near future scientists might be able to prolong life by eliminating the effects of aging.
This fiasco began last summer after Musk became involved in the harrowing effort to rescue 12 boys and their soccer coach from the cave system in Thailand. Unsworth called Musk’s apparent involvement with the effort a “PR stunt” and claimed the billionaire’s divisive miniature submarine concept had “absolutely no chance of working.” In a bizarre and seemingly baseless string of since-deleted tweets, Musk then accused the diver of being a pedophile—a claim he would continue to double down on over the course of months.
“Never saw this British expat guy who lives in Thailand (sus) at any point when we were in the caves,” he tweeted in July. In a follow-up tweet, Musk referred to Unsworth as “pedo guy” before later tweeting: “Bet ya a signed dollar it’s true.”
In a series of emails to BuzzFeed News in September, Musk told the outlet to “call people you know in Thailand, find out what’s actually going on and stop defending child rapists, you fucking asshole.”
“He’s an old, single white guy from England who’s been traveling to or living in Thailand for 30 to 40 years, mostly Pattaya Beach, until moving to Chiang Rai for a child bride who was about 12 years old at the time,” Musk continued. Lawyers for Unsworth have strongly denied all of the allegations, and Musk himself has claimed his “words were spoken in anger” following the diver’s criticism.
Medical technology innovations: Electronic Aspirin. For people who suffer from migraines, cluster headaches, and other causes of chronic, excruciating head or facial pain, the "take two aspirins and call me in the morning" method is useless. Doctors have long associated the most severe, chronic forms of headache with the sphenopalatine ganglion (SPG), a facial nerve bundle, but haven't yet found a treatment that works on the SPG long-term. A technology under clinical investigation at Autonomic Technologies, Inc., (Redwood City, CA) is a patient-powered tool for blocking SPG signals at the first sign of a headache. The system involves the permanent implant of a small nerve stimulating device in the upper gum on the side of the head normally affected by headache. The lead tip of the implant connects with the SPG bundle, and when a patient senses the onset of a headache, he or she places a handheld remote controller on the cheek nearest the implant. The resulting signals stimulate the SPG nerves and block the pain-causing neurotransmitters.
A trial is scheduled for October 22.